Clinical Trial Detail

NCT ID NCT03076554
Title A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

thymoma

thymic carcinoma

Therapies

Avelumab

Age Groups: senior adult

No variant requirements are available.